Zobrazeno 1 - 10
of 7 929
pro vyhledávání: '"Morell M"'
Autor:
Tolan, Nicole V., Uljon, Sacha, Lauren Donnelly-Morell, M., Zhao, Melissa, Mahowald, Grace K., Snyder, Marion L., Contella, Lindsey, Urwiller, Elizabeth D., Daluz Fernandes, Maria, Kang, Phillip, Melanson, Stacy E.F.
Publikováno v:
In Journal of Mass Spectrometry and Advances in the Clinical Lab August 2024 33:14-20
Autor:
De Bono, E., Morell, M., Collet, M., Gourdon, E., Ture Savadkoohi, A., Ouisse, M., Lamarque, C.H.
Publikováno v:
In Journal of Sound and Vibration 3 February 2024 570
Autor:
Vilaplana A; Childhood Cancer and Blood Disorders Research Group, Vall d'Hebron Research Institute, Barcelona, Spain., Morell M; Childhood Cancer and Blood Disorders Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.; Paediatric Haematology and Oncology Division, Vall d'Hebron University Hospital, Barcelona, Spain., Valero-Arrese L; Childhood Cancer and Blood Disorders Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.; Paediatric Haematology and Oncology Division, Vall d'Hebron University Hospital, Barcelona, Spain., Marshall LV; Paediatric & Adolescent Oncology Drug Development Unit, The Royal Marsden NHS Foundation Trust and Division of Clinical Studies, The Institute of Cancer Research, London, UK., Saló A; Paediatric Haematology and Oncology Division, Vall d'Hebron University Hospital, Barcelona, Spain., Crowe T; Paediatric & Adolescent Oncology Drug Development Unit, The Royal Marsden NHS Foundation Trust and Division of Clinical Studies, The Institute of Cancer Research, London, UK., Romero L; Paediatric Haematology and Oncology Division, Vall d'Hebron University Hospital, Barcelona, Spain., de Rojas T; ACCELERATE, Brussels, Belgium., Carceller F; Paediatric & Adolescent Oncology Drug Development Unit, The Royal Marsden NHS Foundation Trust and Division of Clinical Studies, The Institute of Cancer Research, London, UK., Moreno L; Childhood Cancer and Blood Disorders Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.; Paediatric Haematology and Oncology Division, Vall d'Hebron University Hospital, Barcelona, Spain.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Sep; Vol. 71 (9), pp. e31165. Date of Electronic Publication: 2024 Jul 03.
Bank1 modulates the differentiation and molecular profile of key B cell populations in autoimmunity.
Autor:
Gómez Hernández G; Department of Functional Genomics, GENyO, Center for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, Parque Tecnológico de la Salud, Granada, Spain., Domínguez T; Department of Functional Genomics, GENyO, Center for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, Parque Tecnológico de la Salud, Granada, Spain., Galicia G; Department of Functional Genomics, GENyO, Center for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, Parque Tecnológico de la Salud, Granada, Spain., Morell M; Department of Functional Genomics, GENyO, Center for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, Parque Tecnológico de la Salud, Granada, Spain.; Department of Physiology, Faculty of Pharmacy, University of Granada, Campus de Cartuja, Granada, Spain., Alarcón-Riquelme ME; Department of Functional Genomics, GENyO, Center for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, Parque Tecnológico de la Salud, Granada, Spain.; Institute for Environmental Medicine, Karolinska Institute, Stockholm, Sweden.
Publikováno v:
JCI insight [JCI Insight] 2024 Aug 20; Vol. 9 (19). Date of Electronic Publication: 2024 Aug 20.
Autor:
Capell-Morell M; Atenció a la Salut Sexual i Reproductiva (ASSIR) Muntanya, Institut Català de la Salut. Barcelona, Spain., Bradbury M; Gynaecologic Oncology Department, Hospital Universitari Vall d'Hebron. Barcelona, Spain., Dinares MC; Pathology Department, Hospital Universitari Vall d'Hebron. Barcelona, Spain., Hernandez J; Pathology Department, Hospital Universitari Vall d'Hebron. Barcelona, Spain., Cubo-Abert M; Gynaecology Department, Hospital Universitari Arnau de Vilanova. Lleida, Spain., Centeno-Mediavilla C; Gynaecologic Oncology Department, Hospital Universitari Vall d'Hebron. Barcelona, Spain., Gil-Moreno A; Gynaecologic Oncology Department, Hospital Universitari Vall d'Hebron. Barcelona, Spain.
Publikováno v:
AIDS (London, England) [AIDS] 2024 Aug 14. Date of Electronic Publication: 2024 Aug 14.
Autor:
Pérez-Torres Lobato MR; Pediatric Hematology and Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Vall D'Hebron Research Institute (VHIR), Vall d´Hebrón Hospital, Barcelona, Spain., Morell M; Pediatric Hematology and Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Vall D'Hebron Research Institute (VHIR), Vall d´Hebrón Hospital, Barcelona, Spain., Solano-Páez P; Pediatric Oncology Division, Virgen del Rocio Hospital, Sevilla, Spain., Ortiz-Palacios M; Pediatric Hematology and Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Vall D'Hebron Research Institute (VHIR), Vall d´Hebrón Hospital, Barcelona, Spain., Menárgez Á; Pediatric Hematology and Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Vall D'Hebron Research Institute (VHIR), Vall d´Hebrón Hospital, Barcelona, Spain., Panesso M; Pediatric Hematology and Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Vall D'Hebron Research Institute (VHIR), Vall d´Hebrón Hospital, Barcelona, Spain., Vázquez-Gómez F; Pediatric Oncology Division, Niño Jesús Hospital, Madrid, Spain., Moreno-Carrasco J; Pediatric Oncology Division, Niño Jesús Hospital, Madrid, Spain., Lassaletta Á; Pediatric Oncology Division, Niño Jesús Hospital, Madrid, Spain., Santa-María V; Pediatric Oncology Division, Pediatric Cancer Center Barcelona, Barcelona, Spain., Pavon-Mengual M; Pediatric Oncology Division, Pediatric Cancer Center Barcelona, Barcelona, Spain., Quiroga E; Pediatric Oncology Division, Virgen del Rocio Hospital, Sevilla, Spain., García-Ariza MA; Pediatric Oncology Division, Cruces University Hospital, Vizcaya, Spain.; Biobizkaia Research Institute, Cruces University Hospital, Vizcaya, Spain., Mora-Matilla M; Pediatric Oncology Division, Badajoz University Hospital, Badajoz, Spain., Garrido-Colino C; Pediatric Oncology Division, Gregorio Marañón Hospital, Madrid, Spain., Verdú-Amoros J; Pediatric Oncology Division, La Fe University Hospital, Valencia, Spain., Nova-Lozano C; Pediatric Oncology Division, La Fe University Hospital, Valencia, Spain., Vieito M; Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain., Cordero-Asanza EX; Department of Neurosurgery, Vall d´Hebrón Hospital, Barcelona, Spain., Clemente M; Pediatric Endocrinology Division, Vall d´Hebrón Hospital, Barcelona, Spain., Ramos-Albiat M; Department of Radiotherapy, Vall d´Hebrón Hospital, Barcelona, Spain., de Las Morenas-Iglesias J; Ophthalmology Clinic and Refractive Surgery, Baviera Clinic, Barcelona, Spain., Moreno L; Pediatric Hematology and Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Vall D'Hebron Research Institute (VHIR), Vall d´Hebrón Hospital, Barcelona, Spain., Llort A; Pediatric Hematology and Oncology Division, Vall d´Hebrón Hospital, Barcelona, Spain.; Vall D'Hebron Research Institute (VHIR), Vall d´Hebrón Hospital, Barcelona, Spain.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Dec; Vol. 71 (12), pp. e31343. Date of Electronic Publication: 2024 Oct 08.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Creus-Bachiller E; Hereditary Cancer Program, Catalan Institute of Oncology, ICO-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain., Fernández-Rodríguez J; Hereditary Cancer Program, Catalan Institute of Oncology, ICO-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Mouse Lab, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Magallón-Lorenz M; Hereditary Cancer Group, Germans Trias i Pujol Research Institute (IGTP), Barcelona, Spain., Ortega-Bertran S; Hereditary Cancer Program, Catalan Institute of Oncology, ICO-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain., Navas-Rutete S; Hereditary Cancer Program, Catalan Institute of Oncology, ICO-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain., Romagosa C; Department of Pathology, Hospital Vall d'Hebron, Barcelona, Spain., Silva TM; Department of Pathology, Hospital Vall d'Hebron, Barcelona, Spain., Pané M; Department of Pathology, HUB-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Estival A; Department of Medical Oncology, Catalan Institute of Oncology, Barcelona, Spain., Perez Sidelnikova D; Plastic Surgery Service HUB-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Morell M; Hereditary Cancer Program, Catalan Institute of Oncology, ICO-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Mouse Lab, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain., Mazuelas H; Hereditary Cancer Group, Germans Trias i Pujol Research Institute (IGTP), Barcelona, Spain., Carrió M; Hereditary Cancer Group, Germans Trias i Pujol Research Institute (IGTP), Barcelona, Spain., Lausová T; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany., Reuss D; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany., Gel B; Hereditary Cancer Group, Germans Trias i Pujol Research Institute (IGTP), Barcelona, Spain., Villanueva A; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Procure Program, Catalan Institute of Oncology, Barcelona, Spain., Serra E; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hereditary Cancer Group, Germans Trias i Pujol Research Institute (IGTP), Barcelona, Spain., Lázaro C; Hereditary Cancer Program, Catalan Institute of Oncology, ICO-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Publikováno v:
Molecular oncology [Mol Oncol] 2024 Apr; Vol. 18 (4), pp. 895-917. Date of Electronic Publication: 2023 Oct 20.
Autor:
Oltmann J; Department of Ophthalmology, University Hospital Würzburg, Josef-Schneider-Straße 11, 97080, Würzburg, Germany., Morell M; Department of Ophthalmology, University Hospital Würzburg, Josef-Schneider-Straße 11, 97080, Würzburg, Germany., Dakroub M; Department of Ophthalmology, University Hospital Würzburg, Josef-Schneider-Straße 11, 97080, Würzburg, Germany., Verma-Fuehring R; Department of Ophthalmology, University Hospital Würzburg, Josef-Schneider-Straße 11, 97080, Würzburg, Germany., Hillenkamp J; Department of Ophthalmology, University Hospital Würzburg, Josef-Schneider-Straße 11, 97080, Würzburg, Germany., Loewen N; Department of Ophthalmology, University Hospital Würzburg, Josef-Schneider-Straße 11, 97080, Würzburg, Germany. loewen.nils@gmail.com.; ARTEMIS Eye Centers of Frankfurt, Hanauer Landstr. 147, 60314, Frankfurt, Germany. loewen.nils@gmail.com.
Publikováno v:
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2024 Feb; Vol. 262 (2), pp. 537-543. Date of Electronic Publication: 2023 Oct 13.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.